Lore Garten
Addiction Medicine · Kingston, NYNPI 1376507202
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.
Across 72 payments — averaging $36.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$513
- Amgen$398
- AbbVie$273
- Indivior Inc.$149
- Genentech USA, Inc.$146
- Novo Nordisk$125
- plus $1000 from 22 others
What the payments were for
- Speaking & faculty fees$161%
- Food & beverage$2,58099%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 13 | $513 |
| Amgen | 4 | $398 |
| AbbVie(2 entities) | 8 | $273 |
| Indivior Inc. | 3 | $149 |
| Genentech USA, Inc. | 4 | $146 |
| Novo Nordisk | 1 | $125 |
| CSL Behring | 2 | $114 |
| Gilead | 1 | $109 |
| Novartis | 4 | $79 |
| AstraZeneca | 3 | $69 |
| SK Life Science, Inc. | 1 | $56 |
| Grifols USA, LLC | 3 | $56 |
| Alkermes, Inc. | 3 | $55 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| Catalyst Pharmaceuticals, Inc. | 2 | $48 |
| Braeburn Inc. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 1 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Biogen | 2 | $38 |
| Livanova USA, Inc. | 2 | $38 |
| Greenwich Biosciences, Inc. | 2 | $27 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Adamas Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,604 in reported general payments places this provider in the 80th percentile of 125 addiction medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 19 | $58 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Kingston
- Edmond HakimiCalverton$125K
- Alain LitwinBronx$124K
- John MarianiNew York$38K
- Stefan KantrowitzNew York$33K
- Alejo ParelladaBrooklyn$22K
- Sean ChappinAlbany$20K
- Mohammad KabirTroy$15K
- Sonia LopezJamaica$14K
- Thomas KuettelWorcester$14K
- Ramon RaveloNew York$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.